Tech Company Financing Transactions
Aerobiotix Funding Round
Vivo Capital and Asahi Kasei invested in a $25 million funding round for Aerobiotix. The financing round was announced on 5/7/2021.
Transaction Overview
Company Name
Announced On
5/7/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Vivo Capital (Lead Investor) (Joseph Siletto)
Proceeds Purpose
The new funding will be used to accelerate sales, marketing, and new product development.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
444 Alexandersville Rd.
Miamisburg, OH 45342
USA
Miamisburg, OH 45342
USA
Phone
Website
Email Address
Overview
Aerobiotix, Inc. is a privately held company specializing in the development and manufacture of proprietary environmental management devices for use in institutional healthcare, home health, and commercial settings. Aerobiotix has developed a suite of novel technologies for efficient biological elimination of airborne viruses, bacteria and spores to optimize indoor environments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Kirschman
Chief Financial Officer
Michael Schmitz
VP - Engineering
Anthony Defalco
VP - Sales
Nathan Utz
Browse more venture capital transactions:
Prev: 5/7/2021: Astrocyte Pharmaceuticals venture capital transaction
Next: 5/7/2021: Sporos venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs